BF Biosciences starts production from new syringe line

MG News | November 14, 2024 at 03:21 PM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

November 14, 2024 (MLN): BF Biosciences Limited (PSX: BFBIO) has secured approval from Drug Regulatory of Pakistan (DRAP) for its brownfield expansion project along with commencement of commercial production from pre-filled syringes line.

BFBIO shared the development in its notice to the Pakistan Stock Exchange (PSX) on Thursday.

In continuation of the above, the company said the combi filling and lyophilization lines have been commissioned and commercial production has commenced.

Accordingly, the full Line II expansion project stands commissioned from today.

Furthermore, the company said it has already secured approvals for new products from DRAP and intends to launch these products in the coming months.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	168,018.87 212.27M	0.87% 1454.80
ALLSHR	101,001.36 515.85M	0.66% 661.96
KSE30	49,411.77 62.47M	0.83% 408.34
KMI30	240,580.99 77.70M	0.99% 2354.58
KMIALLSHR	65,309.16 294.37M	0.72% 464.00
BKTi	45,925.86 14.05M	0.45% 203.62
OGTi	33,858.81 2.02M	0.58% 194.60

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	77,060.00	77,430.00 76,450.00	220.00 0.29%
BRENT CRUDE	105.86	107.24 104.27	1.09 1.04%
RICHARDS BAY COAL MONTHLY	129.00	129.00 129.00	0.75 0.58%
ROTTERDAM COAL MONTHLY	142.50	0.00 0.00	0.35 0.25%
USD RBD PALM OLEIN	1,182.50	1,182.50 1,182.50	0.00 0.00%
CRUDE OIL - WTI	97.43	98.69 96.12	0.97 1.01%
SUGAR #11 WORLD	18.46	19.06 18.39	-0.60 -3.15%